Citadel Advisors LLC 13D and 13G filings for Decibel Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:55 pm Sale |
2023-12-31 | 13G | Decibel Therapeutics, Inc. DBTX |
Citadel Advisors LLC | 0 0.000% |
-1,863,411 (Position Closed) |
Filing |
| 2023-02-14 08:02 am Purchase |
2022-12-31 | 13G | Decibel Therapeutics, Inc. DBTX |
Citadel Advisors LLC | 1,863,411 7.500% |
35,484 (+1.94%) |
Filing |
| 2022-02-14 06:12 am Purchase |
2021-12-31 | 13G | Decibel Therapeutics, Inc. DBTX |
Citadel Advisors LLC | 1,827,927 7.300% |
39,484 (+2.21%) |
Filing |
| 2021-03-01 4:01 pm Purchase |
2021-02-17 | 13G | Decibel Therapeutics, Inc. DBTX |
Citadel Advisors LLC | 1,788,443 7.400% |
1,788,443 (New Position) |
Filing |